Literature DB >> 32427713

The protective role of Neuregulin1-ErbB4 signaling in a chronic social defeat stress model.

Wenjuan Wang1,2, Yong Qiao1, Huiying Qu2, Lin Zhu2, Linlin Mu2, Chunyue Li1, Jie Fang2, Hong Lian1.   

Abstract

Major depressive disorder (MDD) is a highly prevalent debilitating psychiatric disease and a serious public health problem worldwide. Brain structural MRI and postmortem studies on patients with depression have revealed changes in the anatomy and functionality in various brain regions, including the amygdala, thalamus, hippocampus, and prefrontal cortex (PFC). The alterations in these brain regions could be a result, in part, of the dysregulation of the neurotrophic factors. Neuregulin1 (NRG1) is one of the neurotrophic factors, and our previous study showed that the NRG1-ErbB4 signaling pathway plays a critical role in epilepsy. In this study, we established a chronic social defeat stress (CSDS) model to investigate the role of the NRG1-ErbB4 signaling pathway in depression-like behaviors. In CSDS mice, we found that the NRG1 protein expression levels were significantly decreased both in the medial prefrontal cortex (mPFC) and hippocampus, while phosphorylated ErbB4 only decreased in the mPFC. In addition, lateral ventricle NRG1 administration significantly rescued depression-like behaviors in the susceptible group. The current study suggests that the NRG1-ErbB4 signaling pathway may exert a protective role in MDD.

Entities:  

Year:  2020        PMID: 32427713     DOI: 10.1097/WNR.0000000000001464

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation.

Authors:  Peng Chen; Hongyang Jing; Mingtao Xiong; Qian Zhang; Dong Lin; Dongyan Ren; Shunqi Wang; Dongmin Yin; Yongjun Chen; Tian Zhou; Baoming Li; Erkang Fei; Bing-Xing Pan
Journal:  Cell Death Dis       Date:  2021-04-14       Impact factor: 8.469

Review 2.  MicroRNA-dependent control of neuroplasticity in affective disorders.

Authors:  Helena Caria Martins; Gerhard Schratt
Journal:  Transl Psychiatry       Date:  2021-05-03       Impact factor: 6.222

3.  Mechanism of saikogenin G against major depressive disorder determined by network pharmacology.

Authors:  Lili Hu; Jue Wang; Xiaoge Zhao; Donghui Cai
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

4.  Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.

Authors:  Nabila E Abdelmeguid; Tasneem M Hammad; Ashraf M Abdel-Moneim; Sherine Abdel Salam
Journal:  Neurochem Res       Date:  2022-08-08       Impact factor: 4.414

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.